Enzo Biochem, Inc. (NYSE:ENZ)

CAPS Rating: 2 out of 5

The Company is a life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and a provider of diagnostic services to the medical community.

Recs

0
Player Avatar Greenrunner (26.21) Submitted: 9/7/2007 11:29:27 AM : Outperform Start Price: $12.65 ENZ Score: -79.83

Oversold

Featured Broker Partners


Advertisement